E130012A19Rik Inhibitors

EPOP, or elongin BC and polycomb repressive complex 2 associated protein, plays a critical role in various cellular processes. It is involved in chromatin binding, histone H2B conserved C-terminal lysine deubiquitination, regulation of transcription by RNA polymerase II, and stem cell differentiation. EPOP is part of the ESC/E(Z) complex and the elongin complex, highlighting its multifaceted functions within these molecular assemblies.

The inhibition of EPOP involves targeting its specific functions and associated pathways. The chemicals listed above act as direct or indirect inhibitors by modulating key cellular processes. For instance, Trichostatin A and SAHA, as HDAC inhibitors, impact chromatin structure and may disrupt EPOP's chromatin binding activity, affecting its role in histone H2B deubiquitination. (+/-)-JQ1, a BET bromodomain inhibitor, indirectly influences EPOP by altering the dynamics of the ESC/E(Z) complex, impacting its role in transcriptional regulation. MLN4924, an NEDD8-activating enzyme inhibitor, may disrupt EPOP's involvement in the elongin complex, influencing its role in transcription by RNA polymerase II. In summary, the diverse inhibitors identified provide insights into potential strategies for modulating EPOP function. Understanding the specific pathways and cellular processes associated with EPOP is crucial for developing targeted approaches to inhibit its activity, shedding light on its intricate role in chromatin dynamics, transcriptional regulation, and stem cell differentiation.